Allergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in Aesthetics

Posted By Madilyn Moeller, Tuesday, March 26, 2024

Allergan Aesthetics, an AbbVie company

Allergan Aesthetics, an AbbVie Company, announces Moving the Needle on Ethics- its collaboration with medical aesthetics experts from around the globe aiming to elevate discussions on ethics in aesthetics. The collection of interviews highlights the need for industry-wide transparency and integrity to meet the expected increase in global demand for aesthetics treatments.

The global medical aesthetics industry is set to grow faster than ever before, with 23 million dermal filler and 14.6 million body procedures predicted by 2025.1 With the influx of new practitioners and patients, trusted information, and education to ensure high ethical standards is more important than ever.

"We are at a unique moment in the evolution of our industry, and we must ensure that ethics is front and center in our minds and in our clinical practice," says world renowned aesthetic surgeon Dr. Mauricio de Maio. "A coordinated effort is needed to reconsider the guiding principles of ethics, ensuring patient safety is prioritized."

Read more at PR Newswire >>